Volume | 13,133 |
|
|||||
News | - | ||||||
Day High | 8.51 | Low High |
|||||
Day Low | 8.03 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
United Guardian Inc | UG | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
8.03 | 8.03 | 8.51 | 8.17 | 8.06 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
174 | 13,133 | $ 8.27 | $ 108,549 | - | 5.79 - 12.97 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 7 | $ 8.10 | USD |
United Guardian Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
37.54M | 4.59M | - | 12.7M | 2.57M | 0.56 | 14.60 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
United Guardian News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UG Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.19 | 8.51 | 7.78 | 7.99 | 5,611 | -0.02 | -0.24% |
1 Month | 7.17 | 8.92 | 6.94 | 7.92 | 6,432 | 1.00 | 13.95% |
3 Months | 7.62 | 8.92 | 5.79 | 7.28 | 7,556 | 0.55 | 7.22% |
6 Months | 8.96 | 9.45 | 5.79 | 7.70 | 7,528 | -0.79 | -8.82% |
1 Year | 11.19 | 12.97 | 5.79 | 8.75 | 6,739 | -3.02 | -26.99% |
3 Years | 14.28 | 26.27 | 5.79 | 14.43 | 8,073 | -6.11 | -42.79% |
5 Years | 17.03 | 26.27 | 5.79 | 15.11 | 6,878 | -8.86 | -52.03% |
United Guardian Description
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid and others. The company's pharmaceutical products are sold to and distributed by, full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. |